DrugPatentWatch Database Preview
Indoco Remedies Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for INDOCO REMEDIES, and what generic and branded alternatives to INDOCO REMEDIES drugs are available?
INDOCO REMEDIES has five approved drugs.
There is one tentative approval on INDOCO REMEDIES drugs.
Summary for Indoco Remedies
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Patent Litigation for Indoco Remedies: | See patent lawsuits for Indoco Remedies |
Drugs and US Patents for Indoco Remedies
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indoco Remedies | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202112-003 | Apr 17, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Indoco Remedies | BRIMONIDINE TARTRATE | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 091691-001 | Nov 18, 2014 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Indoco Remedies | FEBUXOSTAT | febuxostat | TABLET;ORAL | 210292-002 | Dec 30, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Indoco Remedies | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202112-001 | Apr 17, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Indoco Remedies | GLIMEPIRIDE | glimepiride | TABLET;ORAL | 202112-002 | Apr 17, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Indoco Remedies | FEBUXOSTAT | febuxostat | TABLET;ORAL | 210292-001 | Dec 30, 2019 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
